TVARDI THERAPEUTICS INC (TVRD:NASDAQ)
$1.76 -0.07 (-3.8251%)
Analysed TVARDI THERAPEUTICS INC (TVRD:NASDAQ) News Sources
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
12-02-2026
yahoo.com
TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know
09-07-2026
yahoo.com
Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
12-08-2026
yahoo.com
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
14-08-2026
yahoo.com
Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
07-07-2026
yahoo.com
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
02-04-2026
yahoo.com
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
31-03-2026
yahoo.com
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
08-05-2026
yahoo.com
Tvardi Therapeutics to Participate in Upcoming Investor Events
21-05-2026
yahoo.com
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
30-07-2026
yahoo.com
What is the current price of TVARDI THERAPEUTICS INC (TVRD:NASDAQ)?
The current price of TVARDI THERAPEUTICS INC (TVRD:NASDAQ) is $1.76.
TVARDI THERAPEUTICS INC (TVRD:NASDAQ) absolute price change since previous trading day?
The absolute price change of TVARDI THERAPEUTICS INC (TVRD:NASDAQ) since the previous trading day is $-0.07.
TVARDI THERAPEUTICS INC (TVRD:NASDAQ) percentage price change since previous trading day?
The percentage price change of TVARDI THERAPEUTICS INC (TVRD:NASDAQ) since the previous trading day is -3.8251%.
What is the most recent average sentiment score for TVARDI THERAPEUTICS INC (TVRD:NASDAQ)?
The most recent average sentiment score for TVARDI THERAPEUTICS INC (TVRD:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for TVARDI THERAPEUTICS INC (TVRD:NASDAQ)?
The most recent sentiment for TVARDI THERAPEUTICS INC (TVRD:NASDAQ) is .
SEC-8K** Filing Available For TVARDI THERAPEUTICS INC (TVRD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.